103 related articles for article (PubMed ID: 3496043)
1. Characterization of a high-molecular-weight form of epidermal growth factor in an extract of human urine.
Mount CD; Lukas TJ; Orth DN
Arch Biochem Biophys; 1987 May; 255(1):1-7. PubMed ID: 3496043
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of epidermal growth factor (beta-urogastrone) and epidermal growth factor fragments from large volumes of human urine.
Mount CD; Lukas TJ; Orth DN
Arch Biochem Biophys; 1985 Jul; 240(1):33-42. PubMed ID: 3874599
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of high molecular weight human epidermal growth factor from human urine.
Tsukumo K; Nakamura H; Sakamoto S
Biochem Biophys Res Commun; 1987 May; 145(1):126-33. PubMed ID: 3297054
[TBL] [Abstract][Full Text] [Related]
4. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
5. The human urinary epidermal growth factor (EGF) precursor. Isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus.
Parries G; Chen K; Misono KS; Cohen S
J Biol Chem; 1995 Nov; 270(46):27954-60. PubMed ID: 7499272
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific for high molecular weight form of human epidermal growth factor.
Koga J; Nishimuro S; Shirono H; Ito C; Yamamoto Y; Matsuo A; Kurobe M; Hayashi K
Biochem Int; 1989 Aug; 19(2):445-52. PubMed ID: 2818606
[TBL] [Abstract][Full Text] [Related]
7. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
8. Conversion of high molecular weight human epidermal growth factor (hEGF)/urogastrone (UG) to small molecular weight hEGF/UG by mouse EGF-associated arginine esterase.
Hirata Y; Orth DN
J Clin Endocrinol Metab; 1979 Sep; 49(3):481-3. PubMed ID: 313937
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of the two-site enzyme immunoassay for human epidermal growth factor (hEGF) and measurement of immunoreactive hEGF in human sera and urine.
Takei Y; Kurobe M; Ezawa H; Hayashi K
J Clin Lab Anal; 1995; 9(2):107-12. PubMed ID: 7714662
[TBL] [Abstract][Full Text] [Related]
10. Some properties of human epidermal growth factor (hEGF)-like immunoreactive material originating from platelets during blood coagulation.
Kurobe M; Tokida N; Furukawa S; Hayashi K
Biochem Int; 1986 Nov; 13(5):729-33. PubMed ID: 3545207
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture.
Kurobe M; Furukawa S; Hayashi K
Biochem Biophys Res Commun; 1985 Sep; 131(3):1080-5. PubMed ID: 3902018
[TBL] [Abstract][Full Text] [Related]
12. Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.
Oka Y; Orth DN
J Clin Invest; 1983 Jul; 72(1):249-59. PubMed ID: 6603475
[TBL] [Abstract][Full Text] [Related]
13. Molecular nature of human epidermal growth factor (hEGF)-like immunoreactivity in human plasma.
Kurobe M; Furukawa S; Hayashi K
Biochem Int; 1986 May; 12(5):677-83. PubMed ID: 3524570
[TBL] [Abstract][Full Text] [Related]
14. Partial purification and characterization of epidermal growth factor in human breast milk.
Hirata Y; Nishimura T; Uchihashi M; Fujita T
Endocrinol Jpn; 1986 Aug; 33(4):433-40. PubMed ID: 3491750
[TBL] [Abstract][Full Text] [Related]
15. Purification of recombinant human epidermal growth factor secreted from the methylotrophic yeast Hansenula polymorpha.
Heo JH; Won HS; Kang HA; Rhee SK; Chung BH
Protein Expr Purif; 2002 Feb; 24(1):117-22. PubMed ID: 11812232
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a low and a high molecular weight form of epidermal growth factor from rat urine.
Nexø E; Jørgensen PE; Thim L; Roepstorff P
Biochim Biophys Acta; 1990 Mar; 1037(3):388-93. PubMed ID: 2310752
[TBL] [Abstract][Full Text] [Related]
17. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
[TBL] [Abstract][Full Text] [Related]
18. Urine human epidermal growth factor (hEGF) levels following surgery.
Abe Y; Miyake M; Sagawa T; Kimura S
Jpn J Surg; 1988 Nov; 18(6):641-6. PubMed ID: 3266767
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human epidermal growth factor in human serum and urine under native conditions.
Aybay C; Karakus R; Yucel A
Cytokine; 2006 Jul; 35(1-2):36-43. PubMed ID: 16908178
[TBL] [Abstract][Full Text] [Related]
20. Assessment by a two-site enzyme immunoassay of human epidermal growth factor (urogastrone) in the urine of patients with various gastrointestinal diseases including malignant tumors.
Kurobe M; Aono M; Moriga M; Furukawa S; Hayashi K
Biochem Int; 1985 Dec; 11(6):817-23. PubMed ID: 3937528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
